Reversal of IKZF1-induced glucocorticoid resistance by dual targeting of AKT and ERK signaling pathways

Although long-term survival in pediatric acute lymphoblastic leukemia (ALL) currently exceeds 90%, some subgroups, defined by specific genomic aberrations, respond poorly to treatment. We previously reported that leukemias harboring deletions or mutations affecting the B-cell transcription factor IK...

全面介紹

書目詳細資料
發表在:Frontiers in Oncology
Main Authors: Miriam Butler, Britt M.T. Vervoort, Dorette S. van Ingen Schenau, Lieneke Jongeneel, Jordy C.G. van der Zwet, René Marke, Jules P.P. Meijerink, Blanca Scheijen, Laurens T. van der Meer, Frank N. van Leeuwen
格式: Article
語言:英语
出版: Frontiers Media S.A. 2022-09-01
主題:
在線閱讀:https://www.frontiersin.org/articles/10.3389/fonc.2022.905665/full

相似書籍